Table 2 Genes with the highest and lowest baseline expression (log2 ratio > |0.4|) in responders compared to non-responders to omega-3 supplementation
Gene | Probe ID | Log ratio* | 95% CI | P value | Biological function/process |
|---|---|---|---|---|---|
HBB | ILMN_2100437 | − 0.74 | (− 1.47 to − 0.01) | 0.05 | Hemoglobin |
KRT72 | ILMN_1695812 | − 0.66 | (− 1.28 to − 0.05) | 0.04 | Cytoskeleton |
ACRBP | ILMN_1784203 | − 0.57 | (− 1.08 to − 0.06) | 0.03 | Acrosin condensation |
UTS2 | ILMN_1732198 | − 0.54 | (− 1.08 to − 0.01) | 0.05 | Vasoconstriction |
RPL23AP7 | ILMN_2222750 | − 0.52 | (− 0.95 to − 0.08) | 0.02 | Unknown |
C21orf7 | ILMN_1699071 | − 0.48 | (− 0.9 to − 0.07) | 0.02 | Unknown |
RPL23AP7 | ILMN_1750273 | − 0.43 | (− 0.8 to − 0.06) | 0.02 | Unknown |
OST4 | ILMN_1739335 | − 0.43 | (− 0.77 to − 0.09) | 0.01 | Glycosylation of polypeptides |
RPS12 | ILMN_1679920 | − 0.43 | (− 0.85 to − 0.01) | 0.05 | Ribosomal protein |
TNNC2 | ILMN_1693428 | − 0.42 | (− 0.83 to − 0.01) | 0.05 | Cytoskeleton |
MIR130A | ILMN_3308808 | 0.42 | (0.05 to 0.80) | 0.03 | Regulation of proliferation |
GNLY | ILMN_1708779 | 0.43 | (0.01 to 0.85) | 0.04 | Inflammation |
RPS26 | ILMN_3299955 | 0.67 | (0.01 to 1.33) | 0.05 | Ribosomal protein |
RPS26 | ILMN_1657950 | 0.68 | (0.03 to 1.33) | 0.04 | Ribosomal protein |
RPS26 | ILMN_3291511 | 0.80 | (0.05 to 1.55) | 0.04 | Ribosomal protein |
RPS26 | ILMN_1750636 | 1.03 | (0.02 to 2.04) | 0.05 | Ribosomal protein |